References
- Breukink E de Kruijff B Lipid II as a target for antibiotics Nat Rev Drug Discov 2006 5 321 332 16531990
- Depardieu F Podglajen I Leclercq R Collatz E Courvalin P Modes and modulations of antibiotic resistance gene expression Clinl Microbiol Rev 2007 20 1 79 114
- Weigel LM Clewell DB Gill SR Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus Science 2003 302 5650 1569 1571 14645850
- Dijkshoorn L Nemec A Seifert H An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nat Rev Microbiol 2007 5 12 939 951 18007677
- Swartz MN Hospital-acquired infections: diseases with increasingly limited therapies Proc Natl Acad Sci U S A 1994 91 7 2420 2427 8146133
- Wisplinghoff H Perbix W Seifert H Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients Clin Infect Dis 1999 28 1 59 66 10028073
- Murray CK Roop SA Hospenthal DR Bacteriology of war wounds at the time of injury Mil Med 2006 171 9 826 829 17036599
- Krol V Hamid NS Cunha BA Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review J Hosp Infect 2009 71 2 176 180 19084290
- McConnell MJ Actis L Pachón J Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models FEMS Microbiol Rev 2013 37 2 130 155 22568581
- Varney KM Bonvin AM Pazgier M Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II PLoS Pathog 2013 9 11 e1003732 24244161
- Orhan G Bayram A Zer Y Balci I Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis J Clin Microbiol 2005 43 1 140 143 15634962
- Falagas ME Kasiakou SK Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections Clin Infect Dis 2005 40 9 1333 1341 15825037
- Li J Nation RL Turnidge JD Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections Lancet Infect Dis 2006 6 9 589 601 16931410
- Li J Nation RL Milne RW Turnidge JD Coulthard K Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria Int J Antimicrob Agents 2005 25 1 11 25 15620821
- Landman D Georgescu C Martin DA Quale J Polymyxins revisited Clin Microbiol Rev 2008 21 3 449 465 18625681
- Pelletier MR Casella LG Jones JW Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii Antimicrob Agents Chemother 2013 57 10 4831 4840 23877686
- Moffatt JH Harper M Harrison P Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production Antimicrob Agents Chemother 2010 54 12 4971 4977 20855724
- Beceiro A Llobet E Aranda J Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system Antimicrob Agents Chemother 2011 55 7 3370 3379 21576434
- Raetz CR Whitfield C Lipopolysaccharide endotoxins Annu Rev Biochem 2002 71 635 700 12045108
- Brogden KA Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005 3 3 238 250 15703760
- Petrosillo N Ioannidou E Falagas ME Colistin monotherapy vs combination therapy: evidence from microbiological, animal and clinical studies Clin Microbiol Infect 2008 14 9 816 827 18844682
- Gordon NC Png K Wareham DW Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii Antimicrob Agents Chemother 2010 54 12 5316 5322 20876375
- Hornsey M Longshaw C Phee L Wareham DW In vitro activity of telavancin in combination with colistin versus Gram-negative bacterial pathogens Antimicrob Agents Chemother 2012 56 6 3080 3085 22491686
- Clinical and Laboratory Standards Institute Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard Eighth Edition 2009